Sustainable transformation in health care hinges on the ability to predict and prevent issues before they arise. This panel will explore how advanced data analytics and AI are not just adding layers of insight but are fundamentally changing the approach to health care. By integrating predictive analytics into everyday operations, these leaders are driving long-term improvements in patient care and system efficiency.

This conversation will explore how innovative partnerships and community-based interventions are revolutionizing our approach to health equity by addressing health disparities at their core. We will showcase leaders who are transforming health care systems through value-based care models that target social determinants of health, creating sustainable and equitable solutions. By shifting the focus from volume to value, these trailblazing strategies are not only fostering long-term improvements in population health outcomes but also ensuring that care delivery is patient-centered and cost-effective. Join us for an inspiring discussion on how these efforts are paving the way for a healthier, more equitable future for all communities.

Empowering patients to take control of their health care is key to transforming the system. This panel will explore how the rise of direct-to-consumer health care—ranging from telemedicine to at-home diagnostics—is doing more than disrupting traditional models: it’s creating a lasting shift toward patient-driven care. By fostering transparency, accessibility, and personalized experiences, innovative companies are building a health care environment that prioritizes long-term patient empowerment.

Investment in health care extends beyond financial returns—it drives innovation, expands access, and shapes the future of patient care. This panel will convene leaders in private equity, venture capital, and institutional investment to discuss emerging funding trends, the evolving balance between profitability and patient-centered outcomes, and the strategies investors are using to identify, scale, and sustain health care solutions.

This panel will explore how precision medicine is moving from niche applications to broader use, and the implications for the pharmaceutical value chain, patient care, and health care costs. Industry leaders will discuss the challenges of safely and rapidly developing and scaling personalized treatments and paradigms while establishing value chains and care delivery pathways that balance affordability and access, all within the context of big data's ever-growing presence in medicine.

As the health care landscape evolves, new models of drug pricing are emerging to address the challenge of driving down costs while maintaining access to essential medications. This panel will discuss new approaches to drug pricing through the lens of pharmaceutical companies, health care providers, payers, and policy makers to explore how these models further the long-term affordability and sustainability of health care systems.